Staphylococcal enterotoxins bind H-2Db molecules on macrophages

Area of Science:

• Immunology
• Molecular Biology

Background:

• Staphylococcal enterotoxins (SEs) are potent immune activators.
• Macrophage interactions with SEs are crucial for immune responses and pathogenesis.
• Major histocompatibility complex (MHC) molecules are key regulators of immune cell interactions.

Purpose of the Study:

• To investigate the role of macrophage cell surface molecules in SE binding.
• To identify specific molecular interactions mediating SE binding to macrophages.
• To evaluate the functional consequences of SE binding to macrophages.

Main Methods:

• Screening of monoclonal antibodies against macrophage surface molecules.
• Assessing inhibition of staphylococcal enterotoxin A (SEA) and B (SEB) binding to C2D macrophages.
• Haplotype specificity analysis of antibody inhibition.
• Measuring enterotoxin-induced cytokine secretion.
• Evaluating passive protection in a mouse model of SE-induced toxicity.

Main Results:

• Monoclonal antibodies HB36 and TIB126, specific for MHC class I alpha 2 domain, inhibited SEA and SEB binding to C2D (H-2b) macrophages.
• Inhibitory activity was MHC haplotype-specific.
• HB36 inhibited enterotoxin-induced cytokine secretion by H-2b macrophages.
• HB36 provided passive protection against SEB-induced lethality in mice.

Conclusions:

• SEA and SEB binding to the MHC class I H-2Db alpha 2 domain induces biological activity.
• This interaction has significant physiological consequences, including cytokine release and lethality.
• Targeting the MHC class I alpha 2 domain represents a potential therapeutic strategy against staphylococcal enterotoxin-induced toxicity.